Effect of Tumor Treating Fields (TTFields, 150 KHz) Concomitant with Chemotherapy As First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma

NCT04281576 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer
GastroEsophageal Cancer

Interventions

DEVICE: NovoTTF-100L(P)
DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: Trastuzumab

Sponsor

NovoCure Ltd.

Collaborators

[object Object]